First, this approach improves discovery by screening for HNF1A-MODY in high-risk populations and, second, it combines clinical and functional investigations into a robust classification scheme that increases precision in diagnosing monogenic diabetes. This evidence concerns the gene HNF1A and diabetes mellitus.